We are live on ! Find out more
GT

Glenmede Trust Portfolio holdings

AUM $20.4B
This Fund
S&P 500
This Quarter Est. Return
+7.57%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$20.9B
AUM Growth
+$1.18B
Cap. Flow
-$95.1M
Cap. Flow %
-0.46%
Top 10 Hldgs %
24.18%
Holding
1,443
New
92
Increased
575
Reduced
559
Closed
58

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$49.3M
2
IQV icon
IQVIA
IQV
+$42.7M
3
IJR icon
iShares Core S&P Small-Cap ETF
IJR
+$34.7M
4
COR icon
Cencora
COR
+$32.7M
5
VOO icon
Vanguard S&P 500 ETF
VOO
+$22.7M

Top Sells

Rank Stock Value
1
VRTX icon
Vertex Pharmaceuticals
VRTX
+$61.8M
2
PGR icon
Progressive
PGR
+$60.9M
3
ANET icon
Arista Networks
ANET
+$23.1M
4
PATH icon
UiPath
PATH
+$22.5M
5
EBAY icon
eBay
EBAY
+$22.2M

Sector Composition

Rank Sector Weight
1 Technology 23.2%
2 Healthcare 11.29%
3 Financials 10.11%
4 Consumer Discretionary 8.76%
5 Industrials 6.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DIOD icon
301
Diodes
DIOD
$3.69B
$13.7M 0.07%
214,396
-3,070
-1% -$213K
NOV icon
302
NOV
NOV
$7.11B
$13.7M 0.07%
+859,708
New +$15.3M
DE icon
303
Deere & Co
DE
$173B
$13.6M 0.07%
32,677
-1,771
-5% -$668K
PRF icon
304
Invesco FTSE RAFI US 1000 ETF
PRF
$9.82B
$13.6M 0.06%
333,709
-1,975
-0.6% -$77.4K
TAP icon
305
Molson Coors Class B
TAP
$7.97B
$13.5M 0.06%
235,116
+26,714
+13% +$1.43M
GS icon
306
Goldman Sachs
GS
$305B
$13.5M 0.06%
27,188
-4,953
-15% -$2.42M
EFOR
307
Everforth Inc
EFOR
$953M
$13.4M 0.06%
144,182
-1,928
-1% -$179K
LECO icon
308
Lincoln Electric
LECO
$14.6B
$13.4M 0.06%
69,964
-11,203
-14% -$2.15M
MOH icon
309
Molina Healthcare
MOH
$10.5B
$13.4M 0.06%
38,910
-28,439
-42% -$9.38M
PD icon
310
PagerDuty
PD
$795M
$13.4M 0.06%
721,633
+75,771
+12% +$1.48M
BLD
311
DELISTED
TopBuild
BLD
$13.3M 0.06%
32,773
-393
-1% -$159K
TSLA icon
312
Tesla
TSLA
$1.21T
$13.3M 0.06%
50,899
+12,955
+34% +$2.95M
IART icon
313
Integra LifeSciences
IART
$1.54B
$13.2M 0.06%
727,781
+405,624
+126% +$9.4M
JBI icon
314
Janus International
JBI
$732M
$13.2M 0.06%
1,305,877
+372,592
+40% +$4.34M
NTRS icon
315
Northern Trust
NTRS
$22.2B
$13.2M 0.06%
146,440
-7,266
-5% -$635K
RMBS icon
316
Rambus
RMBS
$9.49B
$13.2M 0.06%
311,910
+75,908
+32% +$3.68M
IPG
317
DELISTED
Interpublic Group of Companies
IPG
$13.2M 0.06%
415,883
-19,831
-5% -$608K
ASML icon
318
ASML
ASML
$608B
$13.1M 0.06%
15,696
-358
-2% -$320K
CNMD icon
319
CONMED
CNMD
$1.33B
$13M 0.06%
181,099
-2,073
-1% -$146K
ET icon
320
Energy Transfer Partners
ET
$69.5B
$12.9M 0.06%
805,159
+24,375
+3% +$392K
KMI icon
321
Kinder Morgan
KMI
$70.3B
$12.9M 0.06%
582,196
+32,916
+6% +$693K
VZ icon
322
Verizon
VZ
$201B
$12.8M 0.06%
284,538
+5,745
+2% +$240K
OVV icon
323
Ovintiv
OVV
$16.4B
$12.8M 0.06%
333,150
+318,041
+2,105% +$13.7M
TRV icon
324
Travelers Companies
TRV
$82.9B
$12.7M 0.06%
54,410
-290
-0.5% -$63.9K
MLAB icon
325
Mesa Laboratories
MLAB
$559M
$12.6M 0.06%
97,334
-1,442
-1% -$170K
11 12
13
14 15

Similar funds

SLAM
Swiss Life Asset Management Zurich $20.4B AUM 28.71% 1-Year Est. Return
EWA
EP Wealth Advisors Torrance, California $20.3B AUM
MIC
Mubadala Investment Company Abu Dhabi, United Arab Emirates $20.5B AUM 19.39% 1-Year Est. Return
P
&Partners Nashville, Tennessee $20.2B AUM 19.79% 1-Year Est. Return
CI Investments Inc
CI Investments Inc Toronto, Ontario, Canada $20.6B AUM 29.22% 1-Year Est. Return
OSAM
O'Shaughnessy Asset Management Stamford, Connecticut $20.1B AUM 30.42% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return
EIM
Elliott Investment Management West Palm Beach, Florida $20.1B AUM 60.76% 1-Year Est. Return

Glenmede Trust's Q3 2024 Portfolio in Review

As of Q3 2024, Glenmede Trust held 1,443 positions worth $20.9B, up 6% from $19.7B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Glenmede Trust's Q3 2024 filing shows 92 new, 575 increased, 559 reduced and 58 closed positions. Its largest new stake was NOV: 859,708 shares worth $13.7M. The largest sale was Vertex Pharmaceuticals, an estimated $61.8M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.

  • Glenmede Trust's largest Q3 2024 buy was NOV: 859,708 shares worth $13.7M.
  • Glenmede Trust added most to Merck in Q3 2024, an estimated $49.3M increase.
  • Glenmede Trust's biggest Q3 2024 reduction was Vertex Pharmaceuticals, cutting an estimated $61.8M.
  • Glenmede Trust fully exited Pacira BioSciences in Q3 2024, selling an estimated $10.5M.
  • Glenmede Trust's ten largest holdings make up 24% of its $20.9B portfolio in Q3 2024.
  • Glenmede Trust opened 92 new positions and closed 58 in Q3 2024.
  • Glenmede Trust's portfolio value rose 6% quarter-over-quarter to $20.9B.

Based on Glenmede Trust's 13F filing for Q3 2024, filed 13 Nov 2024.